Dr. Georgia Lattanzi on Invariant Natural Killer T Cell Phenotype Switching in Tumors

Andrés sits down with Dr. Georgia Lattanzi to discuss her research on how cancer-linked bacterium rewires invariant natural killer T (iNKT) cells to recruit tumor-promoting neutrophils. She published her findings in Mucosal Immunology in June of 2023.

You can find the show notes here. Reach out to Georgia on LinkedIn if you'd like to discuss her work further.

Reach out to andres@modernvivo to learn how you can be a guest on the show!